Your browser doesn't support javascript.
loading
Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study.
Chakravarty, Jaya; Hasker, Epco; Kansal, Sangeeta; Singh, Om Prakash; Malaviya, Paritosh; Singh, Abhishek Kumar; Chourasia, Ankita; Singh, Toolika; Sudarshan, Medhavi; Singh, Akhil Pratap; Singh, Bhawana; Singh, Rudra Pratap; Ostyn, Bart; Fakiola, Michaela; Picado, Albert; Menten, Joris; Blackwell, Jenefer M; Wilson, Mary E; Sacks, David; Boelaert, Marleen; Sundar, Shyam.
Afiliação
  • Chakravarty J; Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • Hasker E; Institute of Tropical Medicine, Antwerp, Belgium.
  • Kansal S; Department of Community Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • Singh OP; Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • Malaviya P; Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • Singh AK; Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • Chourasia A; Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • Singh T; Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • Sudarshan M; Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • Singh AP; Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • Singh B; Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • Singh RP; Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • Ostyn B; Institute of Tropical Medicine, Antwerp, Belgium.
  • Fakiola M; Cambridge Institute for Medical Research, University of Cambridge, United Kingdom and Telethon Kids Institute, University of Western Australia, Crawley, Australia.
  • Picado A; Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
  • Menten J; ISGlobal, Barcelona Ctr. Int.Health Res. (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
  • Blackwell JM; Institute of Tropical Medicine, Antwerp, Belgium.
  • Wilson ME; Cambridge Institute for Medical Research, University of Cambridge, United Kingdom and Telethon Kids Institute, University of Western Australia, Crawley, Australia.
  • Sacks D; University of Iowa and the Veterans Affairs Medical Centre, Iowa City, Iowa, United States of America.
  • Boelaert M; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, Maryland, United States of America.
  • Sundar S; Institute of Tropical Medicine, Antwerp, Belgium.
PLoS Negl Trop Dis ; 13(3): e0007216, 2019 03.
Article em En | MEDLINE | ID: mdl-30917114

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leishmania donovani / Anticorpos Antiprotozoários / Doenças Endêmicas / Leishmaniose Visceral Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Male País como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leishmania donovani / Anticorpos Antiprotozoários / Doenças Endêmicas / Leishmaniose Visceral Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Male País como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article